FY 2023-2024 Recording of AGM Proceedings_31st AGM_2024 Voting Results & Scrutinizer Report_31st AGM_2024 Chairman Speech_31st AGM_2024 FY 2022-2023 Recording of AGM Proceedings of 30th Annual General Meeting (AGM) Voting Results and Scrutinizer Report of the 30th AGM of the Company FY 2021-2022 Recording of 29th AGM Extra-Ordinary General Meeting (EGM) Extra-ordinary General Meeting Notice – 29.12.2022 Extra-ordinary General Meeting Notice – 29.06.2021

SEBI Circular on ODR – July 31, 2023

Scheme of Amalgamation 2023 Compliance Status Report_NSE Observation Letters Complaint Certificate_15.02.2024 Complaint_Report_OPL_22.03.2024 Audit Committee reports of DLL and OPL Audited financials of last 3 years (financials not being more than 6 months old) of unlisted entity Declaration from the listed entity on any past defaults of listed debt obligations of the entities forming part of the scheme Detailed Compliance report confirming compliance with various regulatory requirements specified for schemes of arrangement Draft Scheme of Arrangement and Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited Fairness opinion by SEBI Registered merchant banker on valuation of assets or shares No Objection Certificate (NOC) from the lending scheduled commercial banksfinancial institutionsdebenture trustees Pre and post amalgamation shareholding pattern of DLL and OPL Report from the Committee of Independent Directors recommending the draft Scheme Statutory auditorsGÇÖ certificate confirming that the accounting treatment contained in the scheme Valuation report from Registered Valuer and Undertaking of no material event impacting the valuation-OPL Scheme of Amalgamation 2021-Withdrawn Observation letter- Scheme of Arrangement and Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited -BSE Limited Observation letter- Scheme of Arrangement and Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited-NSE Limited NSE Complaints report BSE Complaints report Draft Scheme of Arrangement and Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited Valuation report from Registered Valuer and Undertaking of no material event impacting the valuation-OPL Audit Committee reports of DLL and OPL Fairness opinion by SEBI Registered merchant banker on valuation of assets/shares Pre and post amalgamation shareholding pattern of DLL and OPL Audited financials of last 3 years (financials not being more than 6 months old) of unlisted entity Statutory auditors’ certificate confirming that the accounting treatment contained in the scheme is in compliance with all the Accounting Standards (DLL and OPL) Detailed Compliance report confirming compliance with various regulatory requirements specified for schemes of arrangement and all accounting standards. Report from the Committee of Independent Directors recommending the draft Scheme Declaration from the listed entity on any past defaults of listed debt obligations of the entities forming part of the scheme Annual reports of last 3 years of the listed entity No Objection Certificate (NOC) from the lending scheduled commercial banks/financial institutions/debenture trustees No Objection certificates- Dhanuka Laboratories Limited No Objection certificates-Orchid Pharma Limited Request letters for NOC from banks- Dhanuka Laboratories Limited